Skip to main content

Table 2 Pre-existing comorbidities in non-transplant and transplant patients with NDMM stratified by age

From: Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma

 

Overall

< 65 years

65–74 years

75–84 years

85+ years

Non-transplant (N = 22,062)

Transplant (N = 2763)

Non-transplant (n = 5197)

Transplant (n = 1378)

Non-transplant (n = 7741)

Transplant (n = 1298)

Non-transplant (n = 7536)

Transplant (n = 87)

Non-transplant (n = 1588)

Transplant (n = 0)

Charlson Comorbidity Index during 180 days prior to index MM diagnosis

 Mean (SD)

1.5 (1.8)

1.2 (1.5)

0.9 (1.6)

0.7 (1.3)

1.5 (1.8)

1.6 (1.6)

1.6 (1.8)

1.5 (1.3)

2.1 (1.9)

 Median (Q1–Q3)

1.0 (0–2.0)

1.0 (0–2.0)

0 (0–1.0)

0 (0–1.0)

1.0 (0–2.0)

2.0 (0–2.0)

1.0 (0–2.0)

2.0 (0–2.0)

2.0 (0–3.0)

 Min, max

0, 13

0, 11

0, 13

0, 9

0, 12

0, 11

0, 12

0, 5

0, 10

Comorbidities during 180 days prior to index MM diagnosis, n (%)

 Any comorbidity below

14,539 (65.9)

1638 (59.3)

2556 (49.2)

746 (54.1)

5186 (67.0)

826 (63.6)

5476 (72.7)

66 (75.9)

1321 (83.2)

 Cardiac arrhythmia

4327 (19.6)

294 (10.6)

529 (10.2)

139 (10.1)

1396 (18.0)

143 (11.0)

1854 (24.6)

12 (13.8)

548 (34.5)

 Congestive heart failure

2984 (13.5)

117 (4.2)

493 (9.5)

NR

956 (12.3)

59 (4.5)

1179 (15.6)

NR

356 (22.4)

 Hypertension, complicated

3718 (16.9)

260 (9.4)

603 (11.6)

NR

1274 (16.5)

143 (11.0)

1435 (19.0)

NR

406 (25.6)

 Hypertension, simple

11,698 (53.0)

1316 (47.6)

1871 (36.0)

569 (41.3)

4215 (54.5)

692 (53.3)

4490 (59.6)

55 (63.2)

1122 (70.7)

 Hepatic disease

972 (4.4)

151 (5.5)

269 (5.2)

NR

392 (5.1)

71 (5.5)

241 (3.2)

NR

70 (4.4)

 Pulmonary circulation disorders

1027 (4.7)

56 (2.0)

172 (3.3)

NR

357 (4.6)

23 (1.8)

388 (5.1)

NR

110 (6.9)

 Renal impairment

5317 (24.1)

471 (17.0)

932 (17.9)

230 (16.7)

1829 (23.6)

222 (17.1)

2028 (26.9)

19 (21.8)

528 (33.2)

 Valvular disease

2258 (10.2)

158 (5.7)

282 (5.4)

NR

744 (9.6)

90 (6.9)

966 (12.8)

NR

266 (16.8)

  1. MM Multiple myeloma, NDMM Newly diagnosed multiple myeloma, NR Not reported, Q Quartile, SD Standard deviation
  2. Values of 1–10 have not been reported in any cell in this table to conform to the Centers for Medicare and Medicaid Services cell size suppression policy; Similarly, values have not been reported for categorical variables and by subgroup to avoid making it possible to calculate the values of the NR cells